Pairing obinutuzumab with venetoclax in relapsed CLL
Details
Publication Year 2024-05,Volume 65,Issue #5,Page 543-545
Journal Title
Leukemia & Lymphoma
Publication Type
Commentary
Publisher
Taylor & Francis
Keywords
Humans; *Bridged Bicyclo Compounds, Heterocyclic/therapeutic use; *Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy; *Antibodies, Monoclonal, Humanized/therapeutic use/administration & dosage; *Sulfonamides/therapeutic use/administration & dosage; *Antineoplastic Combined Chemotherapy Protocols/therapeutic use/adverse effects; Male; Aged; Middle Aged; Treatment Outcome; Female; Neoplasm Recurrence, Local/drug therapy/pathology; Recurrence
Department(s)
Clinical Haematology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-07-17 07:24:17
Last Modified: 2024-07-17 07:24:25

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙